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Glioblastoma (GBM), the most common primary brain tumor in adults, is an aggressive,
fast-growing and highly vascularized tumor, characterized by extensive invasiveness
and local recurrence. In GBM and other malignancies, cancer stem cells (CSCs)
are believed to drive invasive tumor growth and recurrence, being responsible for
radio- and chemo-therapy resistance. Mesenchymal stem cells (MSCs) are multipotent
progenitors that exhibit tropism for tumor microenvironment mediated by cytokines,
chemokines and growth factors. Initial studies proposed that MSCs might exert
inhibitory effects on tumor development, although, to date, contrasting evidence
has been provided. Different studies reported either MSC anti-tumor activity or
their support to tumor growth. Here, we examined the effects of umbilical cord
(UC)-MSCs on in vitro GBM-derived CSC growth, by direct cell-to-cell interaction or
indirect modulation, via the release of soluble factors. We demonstrate that UC-MSCs
and CSCs exhibit reciprocal tropism when co-cultured as 3D spheroids and their
direct cell interaction reduces the proliferation of both cell types. Contrasting effects
were obtained by UC-MSC released factors: CSCs, cultured in the presence of
conditioned medium (CM) collected from UC-MSCs, increased proliferation rate
through transient ERK1/2 and Akt phosphorylation/activation. Analysis of the profile
of the cytokines released by UC-MSCs in the CM revealed a strong production of
molecules involved in inflammation, angiogenesis, cell migration and proliferation,
such as IL-8, GRO, ENA-78 and IL-6. Since CXC chemokine receptor 2 (CXCR2),
a receptor shared by several of these ligands, is expressed in GBM CSCs, we
evaluated its involvement in CSC proliferation induced by UC-MSC-CM. Using the
CXCR2 antagonist SB225002, we observed a partial but statistically significant
inhibition of CSC proliferation and migration induced by the UC-MSC-released
cytokines. Conversely, CXCR2 blockade did not reduce the reciprocal tropism
between CSCs and UC-MSCs grown as spheroids. In conclusion, we show that
direct (cell-to-cell contact) or indirect (via the release of soluble factors) interactions
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between GBM CSCs and UC-MSCs in co-culture produce divergent effects on cell
growth, invasion and migration, with the former mainly causing an inhibitory response
and the latter a stimulatory one, involving a paracrine activation of CXCR2.
Keywords: mesenchymal stem cell, cancer stem cell, glioblastoma, chemokine, CXCR2, spheroid, co-culture
INTRODUCTION
Glioblastoma (GBM, astrocytoma grade IV according to the
WHO classification) is the most common and aggressive brain
tumor, characterized by rapid growth and poor prognosis
because of outstanding characteristics of invasiveness and
recurrence (Brat et al., 2007; Verhaak et al., 2010). Although
in recent years considerable progress has been made in the
development of novel treatment approaches for GBM, the
median survival time is still less than 15 months (Stupp et al.,
2009). The primary treatment option for GBM is multimodal,
including surgery, followed by radiation and chemotherapy.
However, the infiltrating nature of GBM prevents complete
surgical resection and the tumor rapidly relapses. Moreover, the
benefits of radio- and chemo-therapy are also limited by the
presence of the blood-brain barrier and high toxicity of these
treatments.
Small populations of cancer cells, named cancer stem cells
(CSCs), play a primary role in the development and recurrence
of GBM and most of solid and hematological tumors. CSCs, like
normal stem cells, have the capacity to self-renew, which grants
their persistence within the tumor mass, and to differentiate into
different cell phenotypes originating the main cell populations
forming the tumor (Cruceru et al., 2013). The presence of CSCs
confers to GBM not only a great degree of phenotypic and
cellular heterogeneity, but also the resistance to chemo- and
radio-therapy (Singh et al., 2004; Florio and Barbieri, 2012;
Tanase et al., 2013; Codrici et al., 2016). When transplanted
into immunocompromised mice, CSCs generate tumors that
retain the same histological features and cell heterogeneity of
the original neoplasia (Singh et al., 2004; Friedmann-Morvinski
and Verma, 2014). Moreover, a growing body of evidence
supports CSC plasticity and the de-differentiation ability of
non-CSC ‘‘differentiated’’ tumor cells into CSCs in response to
microenvironmental factors (Friedmann-Morvinski, 2014; Suva
et al., 2014).
Therefore, CSCs play a crucial role in the evolution of
neoplastic diseases and represent a mandatory target to obtain
more efficacious therapeutic responses in tumors (Tanase et al.,
2013). Similarly to normal stem cells, CSCs isolated from
postsurgical human GBM specimens and cultured in chemically
definedmedium (without serum and containing EGF and bFGF),
grow in vitro as spheroids and, typically, although not always,
express CD133 surface marker (Ludwig and Kornblum, 2017).
Importantly, in these culture conditions, CSCs are able to
self-renew and retain tumorigenic activity.
Mesenchymal stem cells (MSCs) are non-hematopoietic
progenitor cells, originally identified in bone marrow as
mononuclear cells that exhibit the capacity to differentiate
into different connective tissue cell types, such as adipocytes,
osteocytes and chondrocytes (Jiang et al., 2002). Although
bone marrow is the most widely used source of MSCs, these
cells can be easily isolated from a variety of tissues including
adipose tissue, placenta, umbilical cord (UC), UC blood,
dental pulp, periodontal ligament and endometrium (Lv et al.,
2014).
In recent years MSCs have gained growing interest for their
intrinsic property to home in damaged tissues, inflammatory
sites and tumors, as well as for their therapeutic potential as
tumor-tropic vectors (Rhee et al., 2015). MSCs possess a marked
tropism toward several types of tumors, including melanoma,
Kaposi sarcoma, Ewing sarcoma, fibrosarcoma, colon, ovarian,
pancreatic, breast and renal carcinomas, and GBM (Bexell
et al., 2010). In addition, MSCs exhibit tumor suppressor
activity in experimental models of glioma, Kaposi sarcoma,
malignant melanoma and other tumors (Rhee et al., 2015;
Zhang et al., 2017). MSCs were also reported to support tumor
growth and metastasis in different malignancies, including colon
cancer, lymphoma and melanoma (Klopp et al., 2011; Yagi
and Kitagawa, 2013). Although MSCs are non-tumorigenic
when xenotransplanted in immune-deficient animals, they
could favor engraftment and progression of cancer cells due
to immunosuppressive and pro-angiogenic properties (Melzer
et al., 2017; Ridge et al., 2017).
UC is a suitable source of MSCs, alternative to bone marrow.
UC-MSCs are plastic-adherent when cultivated in vitro and,
similarly to MSCs derived from other sources, show CD73,
CD90 and CD105 surface markers (Dominici et al., 2006),
while they do not express MHC-II antigens (Troyer and Weiss,
2008). UC-MSCs attracted increasing attention due to their large
availability, easy collection, fast self-renewal, multipotency, low
immunogenicity and the absence of tumorigenicity. Based on
their migratory capability towards cancer cells, many reports
have proposed MSCs as cell therapy to target tumors and to
locally deliver anti-cancer molecules. However, a specific tropism
of UC-MSCs toward CSCs has been rarely described (Shinojima
et al., 2013; Lee et al., 2014; Liu et al., 2014).
MSC homing and migration toward different sites of activity
is mainly mediated by the interactions of chemokines and
chemokine receptors. Chemokines are organized as different
families of peptides produced and released by normal and
neoplastic cells, and are defined on the basis of their ability
to direct migration of leukocytes. Chemokines exert their
biological function through the binding to a large family of
G-protein coupled receptors (Rostène et al., 2011), playing
a relevant role in the regulation of GBM CSC survival and
proliferation (Würth et al., 2014). In particular, the chemokines
IL-8, GROβ and GROα are involved in cell migration and
angiogenesis through the binding to a common receptor, named
CXC chemokine receptor 2 (CXCR2). CXCR2 is a rather
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promiscuous receptor since it also binds other chemokines:
GROβ, ENA-78, GCP-2 and NAP-2; furthermore, a second
receptor, CXCR1, shares with CXCR2 some ligands (IL-8, GCP-2
and NAP-2).
Here, we investigated the effects of UC-MSCs on the
growth and migration of CSCs isolated from three different
human GBMs, and the bidirectional tropism between these cell
populations evaluated in vitro by 3D spheroids and monolayer
cell co-cultures. We demonstrate that UC-MSCs and CSCs own
reciprocal tropism when cultured in 3D, and that their direct
interaction in co-culture affects each other growth rate. However,
UC-MSC-released soluble factors stimulate CSC proliferation
through ERK1/2 and Akt activation. Using pharmacological
inhibitors, we show that CXCR2 ligands released by UC-MSC
promote CSC growth, possibly representing autocrine/paracrine
factors that support GBM CSC proliferation.
Notably, co-cultures of CSCs and UC-MSCs form strong
and compact spheroids, unresponsive to CXCR2 inhibition,
suggesting that physical contact between GBM-CSCs and
UC-MSCs, likely mediated by adhesion molecules, is also an
important regulator of their biological behavior in addition
to, and independently from the soluble chemotactic molecules
released.
MATERIALS AND METHODS
Glioblastoma Stem Cell Isolation and
Growth Conditions
Following informed consent and Institutional Ethical Board
approval, tumor samples, classified as glioblastoma grade IV
(GBM) based on the World Health Organization (WHO)
criteria, were obtained from three patients (48, 41 and
67 year-olds, two females, one male) undergoing surgical
treatment at the Neurosurgery Department, IRCCS-AOU
San Martino-IST (Genova, Italy). Patients underwent surgery
for the first time and did not receive chemotherapy or
radiotherapy. Tumors were immediately processed for single cell
isolation by mechanical dissociation and plated in serum-free
medium (complete stem medium) containing: NeurobasalTM
medium 50%, Dulbecco’s modified Eagle’s medium/F12 50%,
B27 supplement (ThermoFisher Scientific), 2 mM L-glutamine,
100 U/ml penicillin/streptomycin, 2 µg/ml heparin, 15 µg/ml
insulin, 20 ng/ml bFGF and 20 ng/ml EGF (PeproTech; Bajetto
et al., 2013). Cells were used at in vitro culture passages 3–8.
To induce cell differentiation, CSC cultures were shifted to
growth factor-deprived medium containing 10% fetal bovine
serum (FBS, Lonza) for at least 2 weeks.
Glioblastoma Stem Cell Phenotype
Characterization by Immunofluorescence
Cells were fixed with 4% paraformaldehyde, permeabilized
with 0.1% Triton X-100 and immunostained with anti-GFAP
and anti-SOX2 (Abcam, Cambridge UK) antibodies, followed
by fluorochrome-conjugated secondary antibodies (Molecular
Probes, OR, USA) and counterstained with DAPI (Sigma-
Aldrich, Milano, Italy; Würth et al., 2017). Images were acquired
with DM2500 microscope (Leica, Milano, Italy) equipped with
DFC350FX digital camera (Leica).
Isolation and Culture of Human Umbilical
Cord-Derived Mesenchymal Stem Cells
(UC-MSCs)
Seven human UCs (UC 1–7) of both sexes were collected
from women undergoing full-term pregnancy elective cesarean
section, at the Gynecology and Obstetrics Department of
International Evangelical Hospital (Genova, Italy), after written
informed consent and approval by Institutional Ethical Board.
Cords were immediately processed and, after washing in PBS
and vessel removal, mechanically dissociated and placed in
MesenPRO RSTM Medium (Gibco, ThermoFisher Scientific),
with 100 U/ml penicillin/streptomycin (Lonza), at 37◦C in
5% CO2 in air atmosphere. Adherent cells were passed when
they reached about 80% confluence. Passages between two and
six were used for the experiments (Angeletti et al., 2016).
Characterization of UC-MSCs by FACS
Analysis
UC-MSCs were detached with StemPror Accutaser Cell
Dissociation Reagent (Gibco, ThermoFisher Scientific), washed
in PBS and analyzed for CD73, CD105, CD90, CD45, CD34,
CD14, CD11b, HLA-DR expression (Dominici et al., 2006) using
the MSC-Phenotyping Kit (Milteny Biotec GmbH, Germany).
Appropriate IgG isotype-matched antibodies and unstained
cells were used as controls. Dead cells were excluded by
adding 7-aminoactinomycin D (7-AAD; BD Bioscience) prior
to analysis. After staining procedures, cells were acquired by
FACSCanto II flow cytometer (BD Biosciences) and analyzed by
FACSDiva software (BD Biosciences).
In Vitro UC-MSC Multilineage
Differentiation Analysis
Multipotent differentiation was assessed evaluating the ability
of UC-MSCs to differentiate into adipogenic, osteogenic
and chondrogenic lineages under adapted media conditions.
UC-MSCs were plated at 2 × 104cells/well in 24-multiwell
culture plate and grown in StemPror Adipogenesis
Differentiation Kit (Gibco, ThermoFisher Scientific) for
3 weeks, replacing medium every 3 days. Adipogenesis was
assessed using Oil Red O (Sigma-Aldrich) staining to detect
intracellular lipid vacuoles. For osteogenic differentiation
UC-MSCs were plated at 104 cells/well in 24-multiwell culture
plate and grown in StemMACS OsteoDiff Media (Miltenyi
Biotec GmbH, Germany) for 10 days, replacing medium every
3 days. Osteogenesis was assessed by alizarin red S (Sigma-
Aldrich) staining to detect the deposition of intracellular
calcium. Chondrogenic differentiation was assessed by plating
4 × 104 cells/well in NH ChondroDiff Medium (Miltenyi Biotec
GmbH, Germany) for 3 weeks, replacing medium every 3 days.
Chondrogenesis was confirmed using Alcian Blue staining
(Sigma-Aldrich).
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Harvest of Conditioned Medium
UC-MSCs or CSCs were cultured in MesenPRO RSTM medium
or complete stem medium respectively, until cells were
approximately 80% confluent, then cells were washed twice with
PBS and cultured in MesenPRO RSTM medium or DMEM/F12
serum-free medium. After 48 h, conditioned media (CM) were
harvested, centrifuged and filtered through a 0.22 µm syringe
filter and conserved at−20◦C until use.
Cell Viability Assay
Cell viability was evaluated measuring the reduction of
3-(4,5-dimethylthiazol-2-yl)-2,5,diphenyl tetrazolium bromide
(MTT; Sigma-Aldrich). The cleavage of MTT to a purple
formazan product by mitochondrial dehydrogenase was
spectrophotometrically quantified. In brief, treated and control
cells were incubated with 0.25 mg/ml MTT solution in culture
medium at 37◦C for 2 h; after the removal of the medium,
formazan crystals were dissolved in DMSO and absorbance
measured at 570 nm (Massa et al., 2004).
Cell Migration Assay
Cell migration was performed using BD FluoroBlockTM (BD
Biosciences) inserts containing light-tight PET membrane.
2 × 104 cells were plated on 8 µm inserts, previously coated
with diluted (1:400) Matrigel (BD Biosciences), and allowed
to migrate towards control medium (DMEM/F12) or CM.
After 24 h, the inserts were stained with the fluorescent
dye Vybrant carboxyfluorescein diacetate, succinimidyl ester
(CFDA SE) Cell Tracer (Molecular Probes, ThermoFisher
Scientific) following manufacturer’s instructions and cells
migrated to the bottom of membranes were analyzed by
confocal laser-scanning microscope (BioRad MRC 1024 ES)
at 10× magnification, and quantified using the ImageJ
software (NIH, Bethesda, MA, USA; Bajetto et al., 2006).
When indicated SB225002 (Sigma-Aldrich) was used at
50 nM final concentration during both pre-treatment and
experiment.
Cytokine Array Analysis
The RayBio Human Cytokine Array 3 (Ray Biotech, Inc.)
containing antibodies to detect 42 proteins was used to
perform a semi-quantitative evaluation of proteins released
by UC-MSCs and GBM CSCs in CM in comparison with
unconditioned culture medium. One-hundred micrograms of
CM or MesenPRO RSTM medium were analyzed according
to manufacturer’s instructions. Signals were detected by
chemiluminescence reaction with ChemiDoc Imaging system
(BioRad Laboratories) and quantified using Quantity-One
software (BioRad; Thellung et al., 2007).
Co-culture of 3D Spheroids
Green fluorescent protein (GFP)-CSCs were obtained by
retroviral infection with pPLAIN and stably selected by
G418 antibiotic. UC-MSCs were labeled with the fluorescent
dyeVybrant DiI (Molecular Probes, ThermoFisher Scientific;
Thellung et al., 2011). UC-MSC spheroids were generated
culturing cells in complete stem medium or seeding cells on 2%
agarose coated wells in MesenPRO RSTM medium. GFP-CSCs
and DiI-labeled UC-MSCs were confronted in stem complete
medium, MesenPRO RSTM or both media.
Proliferation Analysis by Dye Dilution
Assay
CSCs were starved for 48 h in serum free medium and labeled
with carboxyl CFDA SE (Molecular Probes, ThermoFisher
Scientific) to track proliferating cells before treatments. Intra-
cytoplasmic CFDA equally distributes between daughter cells,
allowing discrimination of successive rounds of cell division by
halving fluorescence signal. CFDA-positive cells were cultured
for 72 h, harvested and washed with PBS for acquisition
by FACSCanto II flow cytometer and analysis by FACSDiva
software (BD Biosciences). Aminimum of 50,000 CFDA-positive
cells were acquired from each sample; for cell viability staining
7-AAD was added to exclude dead cells. To track proliferating
cells, FACS data were analyzed using the Proliferation Wizard
module of ModFitTM LT version 3.0 software (Verity Software
House). Generation number within ProliferationWizardmodule
was set at 10. The proportions of proliferated cells at each division
were obtained by ModFit analysis, which generates histograms
of fluorescence intensity by applying deconvolution algorithms
(Würth et al., 2013).
Real-Time PCR
Total RNA was extracted using the AURUM total RNA Mini
Kit (BioRad), according to the manufacturer’s instructions, and
reverse transcribed into cDNA using iScript cDNA Synthesis Kit
(BioRad). cDNA was amplified using EvaGreen mix (BioRad) on
a CF96 Touch real-time PCR (BioRad). Primers sequences were
as follows:
CXCR1: forward 5′-TGCATCAGTGTGGACCGTTA-3′
and reverse: 5′-TGTCATTTCCCAGGACCTCA-3′; CXCR2:
forward 5′-TGCATCAGTGTGGACCGTTA-3′ and reverse
5′-CCGCCAGTTTGCTGTATTG-3′ (Maxwell et al., 2007);
GFAP: forward 5′-ATCAACTCACCGCCAACA-3′ and reverse
5′-CGACTCAATCTTCCTCTCCAG-3′; GROα (CXCL1):




(CXCL3): forward 5′- CCGAAGTCATAGCCACACTCA-3′
and reverse 5′-CTCTGGTAAGGGCAGGGACC-3′; IL-8
(CXCL8): forward 5′-CTTGGCAGCCTTCCTGATTT-3′ and
reverse 5′-AACCCTCTGCACCCAGTTTT-3. Levels of target
genes in each sample were normalized on the basis of GAPDH
and 28S amplification and reported as relative values (Gritti
et al., 2014).
FACS Analysis
Single CSC cultures, expressing GFP, unstained UC-MSCs,
or co-cultures of both cell types were grown for 72 h,
stained with allophycocyanin (APC) conjugated anti-CD182
(CXCR2; Miltenyi Biotec) in accordance with the manufacturer’s
instructions. Dead cells were excluded by adding 7-AAD (BD
Bioscience) prior to analysis. After staining procedures, cells were
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acquired by FACSCanto II flow cytometer (BD Biosciences) and
analyzed by FACSDiva software (BD Biosciences), as reported
(Pattarozzi et al., 2017).
Western Blot Analysis
Cells were lysed in RIPA buffer containing the ‘‘Cømplete’’
protease inhibitor mixture (Roche Applied Science) for 10 min
at 4◦C. Nuclei were removed by centrifugation (5000 rpm at
4◦C, for 10 min), and total protein content measured using
Bradford assay (Bio-Rad). Proteins (20 µg) were resuspended
in Laemmli buffer (2% SDS, 62.5 mM Tris, pH 6.8, 0.01%
bromophenol blue, 1.43 mM 2-mercaptoethanol, and 0.1%
glycerol), size-fractionated by SDS/PAGE, transferred to PVDF
membrane (Bio-Rad Laboratories), and probed with primary
antibodies (phospho-ERK1/2, α-tubulin, from Cell Signaling).
Probed membranes were incubated with anti-IgG-horseradish
peroxidase-conjugated secondary antibody; immunocomplex
detection and densitometric analysis were performed using
the Immobilon Western Chemiluminescent HRP Substrate and
the Quantity-One Image Chemi-Doc system (all from Bio-Rad
Laboratories). α-tubulin was used as internal control for protein
loading (Florio et al., 2001).
Statistical Analysis
All experiments were repeated at least three times. Data
from quantitative experiments are expressed as mean ± SEM
or± SD. Statistical analysis was performed by One-way ANOVA
with Dunnett’s post hoc test, Mann-Whitney test, two-tailed
t-test using GraphPad Prism 5.02. Statistical significance was
established at p < 0.05.
RESULTS
Isolation and Characterization of Human
Umbilical Cord Mesenchymal Stem Cells
(UC-MSCs) and Glioblastoma-Derived
Cancer Stem Cells (CSCs)
Human UC-MSCs, showing a typical spindle-shaped appearance
(Figure 1, panel a), isolated from Wharton’s jelly, were selected
by the ability to adhere to plastic surfaces. Cells were fully
characterized according to the minimal criteria defined by the
International Society for Cellular Therapy (Dominici et al.,
2006). Flow cytometry analysis of cell surface antigens indicated
that these cells express CD73, CD90 and CD105, which are
considered typical MSC markers, while they were negative
for CD11b, CD14, CD34, CD45 and HLA-DR (Figure 1B).
UC-MSCs showed multilineage differentiation ability acquiring
adipogenic, osteogenic and chondrogenic phenotypes. These
features were demonstrated by accumulation of Oil Red
O-stained lipid droplets (adipocytes, Figure 1A, panel b),
enhanced mineralization, evidenced by Alizarin Red staining
(osteocytes, Figure 1, panel c) and Alcian blue staining in
2D test (chondrocytes, Figure 1A, panel d). Superimposable
results were obtained analyzing cells from all the seven UC
cultures studied. No neutral lipid droplet staining, mineralization
or chondrogenic differentiation occurred when cells were
cultured in control medium (data not shown), and human
fibroblast never generated adipocyte- or osteocyte-like cells
under the same differentiating culturing conditions (data not
shown).
CSCs were isolated from three different human GBMs
(named CSC1-2-3) by their ability to grow as neurospheres
in stem cell permissive medium, containing bFGF and EGF
in the absence of FBS (complete stem medium, see ‘‘Materials
and Methods’’ section; Figure 2A). Growing the cells in the
absence of growth factors, a marked reduction in the ability of
CSCs to proliferate in vitro was observed that was completely
abolished culturing the cells in plain DMEM/F12 medium
(see Supplementary Figure S1). In the absence of growth
factors, CSCs also lose spherogenic ability (Supplementary
Figure S2). However, when growth factors were replaced
with FBS, GBM CSCs are induced to differentiate, evidenced
by morphological change, surface adhesion, and growth as
monolayer (Figure 2A). CSCs express stemness-associated
markers, such as SOX2 (Figure 2B), nestin and CD133
(data not shown), while differentiated cells show increased
expression of the astrocytic protein GFAP, as shown in
immunofluorescence experiments (Figure 2B). These results
were confirmed by qRT-PCR, showing increased GFAP mRNA
levels in differentiated cells from all the three GBMs as
compared to the respective CSCs (Figure 2C). All GBM
CSC cultures used in this study have been evaluated in
previous experiments for the ability to form tumors when
orthotopically xenotransplanted in the brain of NOD/SCID
mice, confirming the retaining of tumorigenic activity even after
prolonged in vitro growth (Corsaro et al., 2016; Falcone et al.,
2016).
Reciprocal Tropism between UC-MSCs
and CSCs and in Vitro Invasion
Several studies reported that tumor-derived soluble factors
mediate the chemotactic tropism of MSCs toward GBM
cells (Bexell et al., 2010). We used a spheroid confrontation
invasion assay as model to monitor migration ability of
the different cell types, since cells grown as multicellular
spheroids closely recapitulate the in vivo biological behavior
of solid cancers. CSC-enriched cultures from all the three
GBM analyzed (CSC1, CSC2, CSC3) were infected with a
retrovirus expressing the GFP protein to trace cells through
the experiments, while UC-MSCs were marked out with the
red fluorescent lipophilic dye DiI (Thellung et al., 2011). CSCs,
cultured in stem cell-permissive medium, grow as spheroids
(Griffero et al., 2009; Gatti et al., 2013); in contrast, UC-MSCs
grow as adherent cells in standard culture conditions. To
generate multicellular spheroids of UC-MSCs, these cells were
grown in mesenchymal defined medium on agar feeder, to
prevent plastic adhesion or, alternatively, in complete stem
cell medium, in which both CSCs and UC-MSCs grow as
spheroids (see ‘‘Materials and Methods’’ section). Co-culture
experiments using spheroids of both cell types were performed
in the different culture conditions (mesenchymal defined
medium on agar-coated plates or without coating) and their
Frontiers in Cellular Neuroscience | www.frontiersin.org 5 October 2017 | Volume 11 | Article 312
Bajetto et al. Mesenchymal/Glioblastoma Stem Cell Interaction
FIGURE 1 | Phenotypic and functional characterization of human umbilical cord (UC)-mesenchymal stem cells (MSCs). (A) Representative images showing the
morphology of UC-MSCs isolated from UC-1 and their differentiation into adipogenic, chondrogenic and osteogenic lineages (the same characterization was
performed on all the seven established UC-MSC cultures, obtaining superimposable results): (a) spindle-shaped morphology of MSCs derived from Wharton’s jelly of
UC; (b) adipocytes: red lipid vacuoles stained with the lipophilic dye Oil-Red-O; (c) osteocytes: alizarin red staining of calcium deposit; (d) chondrocytes: cartilage
matrix staining with alcian blue. (B) Immunophenotypic characterization of UC-MSCs. Flow cytometry experiments revealed that UC-1-MSCs are positive for the
typical MSC markers CD105, CD90, CD73, while lack the expression of the hematopoietic markers CD34, CD45, CD14, CD20 (all in the PerCP-A channel);
histograms are representative of the results obtained with all the seven established UC-MSC cultures.
migration and interactions were documented by confocal
microscopy.
When, confronted in the absence of cell adhesion to the plastic
support (agar coating), single spheroid of CSCs and UC-MSCs
entered in close contact after only 1 day of co-culture, and a red
core (UC-MSCs) was appreciable within green aggregates of both
CSC1 and CSC2 (Figure 3, panel Ai). After 4 days, the majority
of UC-MSCs and CSC1 (or CSC2) appeared to be strongly
intertwined with each other in the same spheroid structure
(Figure 3, panel Ai). In the absence of agar, spheroids attached
to the plastic surface and both CSC1 and CSC2 cultures strictly
adhered to UC-MSCs, as observed in the three-dimensional
spheroids (Figure 3, panel Aii). The confrontation of UC-MSC
and CSC spheroids in complete stem medium showed a similar
biological behavior. Acquisition of laser confocal images after 1,
2 (not shown) and 8 days (Figure 3B) showed a bidirectional
tropism. In particular, DiI-labeled UC-MSCs migrated into
GFP-expressing CSC spheroids, as well as invasion of the red
UC-MSCs spheroid by green CSCs was evident, indicating an
active reciprocal tropism of the two cell types in both culture
media (Figure 3B). Similar results were obtained when dispersed
single cells from UC-MSCs and GFP-CSC1 or GFP-CSC2
or GFP-CSC3 were seeded together either in complete stem
medium or in the mixture of complete stem cell medium plus
defined mesenchymal medium (1:1). After 2 days of co-culture,
both cell types interacted forming mixed red-green spheroids in
complete stemmedium (Figure 3, panel Ci) or partially adherent
spheroids in mixed medium (Figure 3, panel Cii).
These results suggest that UC-MSCs and GBM-CSCs are
able to migrate toward each other forming mixed spheroids
independently from the culture conditions used, and that their
integration does not produce apparent phenomenon of cell
death, even after 8 days of co-culture.
Reciprocal Control of Proliferation
between GBM CSCs and UC-MSCs
To determine whether direct contact between GBM CSCs and
UC-MSCs is required to interfere with tumor growth, CSC
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FIGURE 2 | Characterization of glioblastoma (GBM) cancer stem cells (CSCs). (A) Morphological appearance of CSCs grown as floating spheres in complete stem
medium (Stem) and as monolayers after induction of differentiation in serum-containing medium (Diff.). (B) Representative immunofluorescence images of Sox2 (red
nuclear staining) and GFAP (red cytoskeleton staining) expression in CSCs before and after induction of differentiation in serum-containing medium. Nuclei were
counterstained with DAPI (blue). Scale, 100 µm. (C) Quantitative RT-PCR of GFAP mRNA levels in CSC1, CSC2 and CSC3 cells cultured in complete stem medium
or after differentiation. Normalized values are referred to stem condition. Values are expressed as the mean of three experiments ± SD.
proliferation was evaluated using CFDA-SE dye dilution assay
analyzed by flow cytometry, that allows cell division tracking
as sequential halving of initial fluorescence in daughter cells.
CSC1, CSC2 and CSC3 were labeled with CFDA-SE and then
cultured in the absence or presence of UC-MSCs, in stem
complete medium for up to 72 h. Proliferation analysis was
performed by FACS every 24 h, evaluating the decline of
CFDA-SE fluorescence due to dye distribution in daughter cells
(Figure 4). CSC growth rate after 72 h was significantly reduced
when co-cultured with UC-MSCs, as evidenced by the delay
in fluorescence leftward shift, as well as by reduction of the
proliferation index (p.i.), as compared to control CSC cultures. In
detail, in the presence of UC-MSCs, the slow-down of CSC1 and
CSC3 proliferation occurred as a reduction of the percentage of
cells that engaged the third and the fifth cell division, respectively,
and was quantified by the decrease of the p.i. from 7.5 to
5.6 for CSC1 and from 7.8 to 6.8 for CSC3 (Figure 4). In
CSC2 the presence of UC-MSCs had a minor effect, with a
reduction of p.i. from 7.3 to 6.7. Moreover, CSC proliferation
kinetics was modified by co-culture with UC-MSCs: although,
as observed in control cells, proliferating CSCs progress up to
the fifth generation after 72 h, this occurred in a significant
lower percentage of cells (5.74 vs. 12.4, 13.4 vs. 19.82 and
9.47 vs. 26.96 for CSC1, CSC2 and CSC3, respectively). Notably,
a similar pattern of cell division slowdown was observed in
all the cultures, although slightly less pronounced in CSC2
(Tables in Figure 4). Taken together these data suggest that
the direct interaction with UC-MSCs induces inhibition of CSC
proliferation.
To better understand this phenomenon, we evaluated
by immunocytofluorescence the expression of Ki-67 nuclear
antigen, an index of cell proliferation, in GFP-CSC1, GFP-CSC2
and UC-MSCs monocultures or after their co-culture for 48 h
in complete stem cell medium (Figure 5A). Histograms reported
in Figure 5B show that, after 2 days of cultures, Ki-67 positive
stain (red) was present in 92 and 90% of GFP-CSC1 and GFP-
CSC2, respectively (green); in UC-MSC (evidenced by blue
nuclei without cytosol green stain), Ki-67 antigen was detected
in 85% of the cells. However, when co-cultures were established,
a significant reduction of Ki-67 antigen expression occurred in
GBM CSCs (from 92% to 63% in CSC1 and from 90% to 67%
in CSC2; Figure 5B), demonstrating that in the presence of
UC-MSCs both CSC cultures reduced the proliferation rate, in
line with the FACS results described in Figure 4. A remarkable
reduction of Ki-67 was also observed in UC-MSCs: in the
presence of CSC1 or CSC2, Ki-67 expression was detected in
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FIGURE 3 | Co-culture of GBM CSCs and UC-MSCs in 3D spheroids (images of UC-2-MSC cultures are reported, but the same results were obtained also using
UC-3-MSC). (A) Time-dependent integration of 3D spheroids of green fluorescent protein (GFP)-CSC1, GFP-CSC2 (green) and DiI-stained UC-MSCs (red),
co-cultured in mesenchymal defined medium in the presence (i) or absence (ii) of agar coating, analyzed by confocal microscopy after 1 and 4 days. Scale bar,
160 µm. (B) Analysis by confocal microscopy after 8 days of co-culture of spheroids of GFP-CSC1 or GFP-CSC2 (green) and spheroids DiI-stained UC-MSCs (red)
formed in complete stem cell medium. Scale bar, 50 µm. In small images only green or red channel of mixed spheroid are shown. (C) Analysis by confocal
microscopy after 2 days of co-culture of GFP-CSC1, GFP-CSC2, GFP-CSC3 (green) and DiI-stained UC-MSCs (red) cells co-cultured in complete stem cell medium
(i) or mixed complete stem medium and defined mesenchymal medium 1/1 (ii). Scale bar, 50 µm.
only 17% or 15% of UC-MSCs, respectively (Figure 5B). The
morphology of nuclei counterstained with DAPI confirmed the
absence of apoptosis in both cell types.
These results clearly show that direct cell-to-cell interaction
of co-cultured CSCs and UC-MSCs causes a reduction of
proliferation rate of both cell types.
UC-MSC Conditioned Media Induce CSC
Growth through ERK1/2 and Akt Activation
To identify possible UC-MSC-dependent factors that may
influence CSC proliferation, we evaluated the growth of CSC1,
CSC2 and CSC3 in the presence of UC-MSC-derived CM
collected from seven different UC-MSC cultures after 48 h of
growth in serum free DMEM/F12 medium. Proliferation was
assessed after 72 h from the addition of CM, using the MTT
assay. Unexpectedly, the results evidenced that all UC-MSC CM
induced a consistent increase in cell proliferation, averaging
+69% in CSC1, +167% in CSC2, and +51% in CSC3 in
comparison to control cells grown in DMEM/F12 medium
(Figure 6A, see Supplementary Figure S3 for the effects of
individual media). As further control, we tested the effects
of UC-MSC-derived CM on the growth of UC-MSCs without
observing any modification of proliferation rate (data not
shown), while CM from the three CSC cultures did not
induce UC-MSC proliferation (Supplementary Figure S4). Thus,
a monodirectional regulation of cell proliferation was only
observed, induced by soluble factors released by UC-MSCs and
acting on GBM CSCs.
To investigate the intracellular signaling mediating the
CSC proliferation induced by UC-MSC CM, we quantified
by Western blotting the phosphorylation/activation
status of ERK1/2 and Akt kinases, which are critical
mediators of pathways regulating CSC growth and survival
(Griffero et al., 2009; Würth et al., 2013). A strong transient
phosphorylation of ERK1/2 was detected in all CSC cultures after
30 min of exposure to UC-MSC CM, which returned to basal
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FIGURE 4 | UC-MSC co-culture reduces GBM CSC proliferation rate. The proliferation rate of CSC1, CSC2 and CSC3 was tracked by carboxyfluorescein diacetate,
succinimidyl ester (CFDA SE) dye dilution and analyzed by flow cytometry. The distribution of CSC1, CSC2 and CSC3 cells among generations after 72 h of
co-culture with UC-MSCs (1:1) is depicted in histograms, each curve represents a new generation that occurred, starting from the parental cells (blue curve). The
quantification of the data is summarized in the corresponding tables. Proliferation index (p.i.) is reported on the top of tables representing the sum of cells in all
generations divided by the number of original parent cells. Representative data of three independent experiments using different UC-MSCs (1, 3 and 4) are shown.
levels after 60 min (Figure 6B). Likewise, the phosphorylation
of Akt in response to UC-MSC CM was maximal after 30 min,
and declined, although still slightly detectable, after 60 min in
CSC3 culture (Figure 6B). Alpha-tubulin levels, used as internal
control, remained unchanged in all the experimental conditions.
These results suggest that UC-MSCs release soluble factors
which exert a stimulatory activity on CSC proliferation through
a transient activation of both ERK1/2 and Akt pathways.
Cytokine Profile in UC-MSC and in CSC
Conditioned Media
Chemokines, and cytokines in general, are major players
mediating MSCmigration toward tumor tissues. The contrasting
results we evidenced by the co-culture of UC-MSCs and CSCs
and the activity of soluble components of UC-MSC CM,
prompted us to analyze UC-MSC and CSC cytokine secretome
using a commercial cytokine antibody array (Figure 7A).
To evaluate the cytokine profile released from UC-MSCs
we collected the supernatants after 48 h of culture in
standard conditions (MesenPRO medium) and used this
uncultured medium as control. The results evidenced the
presence of multiple chemokines and cytokines, some of
which were already components of the MesenPro medium
and others specifically produced by UC-MSCs (Figure 7A).
To quantify the amount of cytokines released by UC-MSCs,
spots on membranes were analyzed by densitometry and
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FIGURE 5 | Modulation of the growth fraction of GBM CSCs expressing GFP and UC-MSCs as single culture or co-culture systems (images of UC-5-MSC cultures
are reported, but the same results were obtained also using UC-6-MSC). (A) Representative immunofluorescence staining for Ki-67 (red) in GFP-CSC1 (green),
GFP-CSC2 (green), UC-MSCs (not stained) or in GFP-CSC1/UC-MSC and GFP-CSC2/UC-MSC co-cultures after 2 days. Nuclei are counterstained with DAPI (blue).
Scale bar, 100 µm. (B) Quantification of Ki-67 staining was obtained using ImageJ Software. Total number of cells was identified by DAPI nuclear staining. The
number of UC-MSCs was obtained by difference from the number of blue stained cells and those green stained (CSCs). CSC Ki-67-positive are identified by triple
staining green/red/blue; CSC Ki-67-negative by double staining green/blue; UC-MSC-Ki-67-expressing cells show double staining red/blue and
UC-MSC-Ki-67 negative only blue staining. Histograms represent the % of Ki-67-expressing cells ± SEM among the total number of cells counted in four different
fields for each conditions, identified by DAPI nuclear staining.
plotted after subtraction of the respective spots detected in
MesenPRO medium (Figure 7B). The cytokines released at
higher levels by UC-MSCs were GRO, GROα, IL-6, IL-8 and
MCP-1 (Figure 7B). UC-MSC CM, collected in serum free
medium DMEM/F12 (in which no cytokines are present),
showed a similar cytokine content profile indicating that this
activity is independent from the culture conditions (data
not shown). Importantly, the cytokines secreted in higher
amounts by UC-MSCs are mainly characterized by a positive
activity on angiogenesis, inflammation, cell migration and
tumorigenesis, rather than playing antiproliferative or cytostatic
roles.
As far as CSCs, the pattern of cytokines secreted was analyzed
using the same antibody array. CSC CM was collected after
growing CSC1, CSC2 and CSC3 in serum free medium for
48 h. Results showed that CSCs secrete a different pattern
of cytokines from UC-MSCs, being non-always overlapping
between CSC1, CSC2 and CSC3 (Figure 8). The simultaneous
screening of different cytokines demonstrated that the most
represented molecules found in the CM from all CSC cultures
include oncostatin M, angiogenin, TNF-α and β, TGF-β1,
RANTES, MCP-1, MIP-1δ, M-CSF, IL-10, IL-8, IL-1 α and β,
IL-3 and GRO (Figure 8). These experiments also highlighted
that CSC2 secrete higher level of GRO, IL-8, MCP-1 and
angiogenin as compared to CSC1 and CSC3, which, in
contrast, showed a more homogeneous cytokine secretome.
Notably, the secretion of these cytokines (GRO, IL-8 and
MCP-1) was observed at high levels in both CSCs and
UC-MSCs.
As shown in Figure 9, the pattern of cytokine released
by both CSCs and UC-MSCs was changed when the two
populations were co-cultured. The analysis was performed by
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FIGURE 6 | UC-MSC conditioned medium (CM) promotes the growth of GBM CSCs through ERK1/2 and Akt activation. (A) CSC growth was analyzed after 72 h of
culture in the absence (CTR) or presence of UC-MSC-derived CM by MTT assay. Columns represent the mean of seven different CM tested ± SD (the effects of
individual CM are reported in Supplementary Figure S3). Statistical analysis was performed with One-way ANOVA p < 0.0001 with post hoc analysis by the Dunnett’s
test ∗∗∗p < 0.001. (B) Representative Western Blot analysis showing the expression of phospho-ERK1/2 and phospho-Akt in control (time 0) CSCs and after
stimulation with UC-MSCs CM for 30 min or 60 min. Hybridization with total α-tubulin was used as loading control.
comparing the levels of cytokines released in the medium for
48 h in co-culture with the levels obtained by the sum of
cytokines released by CSCs and UC-MSCs grown separately.
Interestingly, while co-culture did not modify the release of
some peptides (i.e., SCF, SDF-1, GRO-α, IL-7) independently
from which cell type mainly released the cytokine, a general
inhibitory pattern was observed for most of the secreted
proteins. In particular, an inhibitory trend was observed in the
co-culture as far as ENA-78, IL-6 and IL-10 mainly produced by
UC-MSCs, and M-CSF, MIP-1δ, RANTES, TNF-α, angiogenin,
and oncostatin M, mainly released by CSCs. A more complex
pattern was observed for GRO, MCP-1 and IL-8, that are
released at high levels by UC-MSCs and CSC2. In the coculture
UC-MSC/CSC2 the release of all these peptides was inhibited,
while it was potentiated co-culturing UC-MSC and CSC1 or
CSC3, as far as GRO, MCP-1, but remained unchanged for IL-8.
Validation of chemokine expression in UC-MSC and CSC1-3
was performed for few relevant genes (in particular, the GRO
isoforms and IL-8) by qRT-PCR, confirming the expression of
all genes (Supplementary Figure S5).
CXCR2 Inhibitor Mediates
Anti-Proliferative and Anti-Migratory
Effects in CSC2 and CSC3 Co-cultures
with UC-MSC CM without Affecting Their
Spheroid Formation and Invasion Capacity
IL-8, GROs and GROα which represent the chemokines mainly
involved in cell migration and angiogenesis, share CXCR2 as
common receptor. We used the specific CXCR2 antagonist
SB225002 to study the role of the activation of this receptor in
the proliferative activity exerted by UC-MSC CM on CSCs, and
in the CSC/UC-MSC spheroid formation and invasion. First,
we demonstrated that both CXCR1 and CXCR2 mRNAs are
expressed in all CSCs (Figure 10A). Their expression was clearly
evident in cultures maintained under growth factor starved
conditions (ST; Figure 10A), while a weaker expression was
detected in CSC1 and CSC3 maintained in standard conditions
(stem cell medium, SC, Figure 10A) and it was almost absent in
CSC2 culture. These results were confirmed at protein level, by
FACS analysis (Figure 10B) in which CXCR2 protein expression
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FIGURE 7 | Profile of cytokines secreted into the CM of UC-MSCs. The expression level of a panel of cytokines was analyzed using a human cytokine array in the
CM from three independent UC-MSCs (3, 4 and 5) harvested after 48 h of culture. The different CM analyzed induced highly reproducible results. (A) Representative
blots of cytokines found in MesenPRO medium (upper panel) and in mesenchymal medium (lower panel); boxes represent the positive (solid line) and negative
(dotted line) controls, respectively. (B) Densitometric analysis for quantification of cytokine spots, after subtraction of cytokine spots found in mesenchymal medium.
Results are reported as arbitrary units (AU) of signal intensity in controls (CTR) and CM of UC-MSCs. Data are normalized after background subtraction.
was detected in all CSCs and barely modified by changing the
culture conditions.
CSC1, CSC2 and CSC3, pretreated with SB225002 for 48 h
in complete stem medium, were challenged for 72 h with
UC-MSC CM individually collected from seven independent
cultures, in the presence or absence of the CXCR2 inhibitor,
and cell growth was analyzed by MTT assay. CXCR2 blockade
significantly reduced cell proliferation in CSC2 and, although
at lower extent, CSC1 and CSC3 cultures (Figure 11A). These
differential data likely reflect individual features of CSCs derived
from different GBMs, with CSC2 growth being more dependent
on CXCR2 signaling than the other cells. In fact, the possible
‘‘addiction’’ of CSC2 for CXCR2 ligands was also suggested by
the higher basal production of IL-8 and GRO as compared to
CSC1 and CSC3.
To delve deeper into the mechanisms of the interaction
and invasion of spheroids formed by the different cell types,
we analyzed by confocal laser microscopy GFP-CSC2 and
GFP-CSC3 cells co-cultured with UC-MSCs, pretreated with
SB225002 for 48 h, after 1 and 6 days in complete stem
cell medium. The presence of SB225002 did not modify
neither spheroid formation nor invasion of CSC2 and CSC3 or
UC-MSCs within spheroids (Figure 11B), even after 6 days
of co-culture. Nevertheless, the inhibition of CXCR2 activity
markedly reduced CSC2 migration (33% of reduction), as
assayed by transwell migration assays, whereas, in the same
experimental conditions, it did not affect CSC3 migration
(Figures 11C,D). Notably, CXCR2 expression in co-culture
conditions was only marginally modified in both all GBM CSCs
and UC-MSC (Figure 10C), suggesting that the lack of effects of
the CXCR2 inhibitor on spheroid invasion and cell migration is
not dependent on receptor dynamics.
These results suggest that CXCR2 activation by secreted
ligands controls CSC growth and migration, although individual
differences are detectable among cultures derived from different
GBMs. Conversely, SB225002-mediated inhibition of CXCR2 did
not influence spheroid formation and invasion ability of both
CSC2 and CSC3 co-cultures with UC-MSCs.
DISCUSSION
In the past years, MSCs demonstrated glioma-targeting behavior
after transplant into rat brain. MSCs were reported to migrate
along the corpus callosum toward the area where GBM
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FIGURE 8 | Cytokines profile in CSC1, CSC2 and CSC3 cells. CM were collected from CSC1, CSC2 and CSC3 cultures after 48 h in serum free medium. Cytokine
antibody arrays were performed and quantification analysis was done by densitometry of cytokine spots, reported as AU of signal intensity. Data are normalized after
background subtraction.
was established in the contralateral hemisphere or in distant
microsatellites (Nakamura et al., 2004), and to home into glioma
after injections into the ipsilateral and contralateral carotid
arteries (Nakamizo et al., 2005). Moreover, in vitro studies
demonstrated MSCs to possess direct anti-tumor properties,
impairing the growth of GBM cell lines and patient-derived
primary GBM cultures, while the co-injection of MSCs and
GBM cells resulted in a significant reduction of volume and
vascularization of the tumor developed in vivo (Ho et al., 2013).
However, contrasting observations were also reported,
supporting the possibility that MSCs actually promote tumor
development and growth through stimulation of cancer cell
proliferation or favoring angiogenesis and immunosuppressive
activity (Lazennec and Jorgensen, 2008; Klopp et al., 2011).
Most of the studies concerning the trophic or pro-apoptotic
properties of MSCs toward tumors were carried out in GBM
established cell lines, and only few reports focused on MSC
interaction with human CSCs, even though this rare tumor
cell subpopulation, responsible of tumor recurrence and drug
resistance, represents the main pharmacological target to
eradicate neoplasms (Shinojima et al., 2013; Liu et al., 2014).
In the present study, we investigated how specific cellular
interactions between CSCs and UC-MSCs affect in vitro
proliferation of both populations. We identified different and
sometimes contrasting effects deriving from the interaction
between UC-MSCs and three GBM-derived CSC cultures as
far as their ability to control cell proliferation, invasion and
migration.
Using 3D spheroid invasion assay, we show that UC-MSCs
and CSCs possess a reciprocal tropism, with both cell types
able to infiltrate the counterpart spheroid, and to form compact
spheroids including closely integrated cells of both populations.
This activity was observed in different experimental conditions
and was independent from the culture medium used in the assay,
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FIGURE 9 | Effects of co-culture of CSC1, CSC2 and CSC3 with UC-MSC-CM on cytokine release. CM were collected from CSC1, CSC2 and CSC3 cultures after
48 h of co-culture with UC-6-MSC in DMEM/F12 medium. Data are compared with the densitometry results obtained by the sum of the cytokines released by CSCs
and UC-MSCs mono-cultures. The same protein arrays described in Figures 7, 8 were used, but for sake of clarity, only the values of cytokines that resulted,
modified in the co-cultures are reported. Data are the average of two determinations.
considering that the two cell types normally grow in the presence
of different medium formulations. This process was particularly
evident in CSC2 culture. This observation is of utmost relevance
considering that the lethal clinical outcome of GBM mainly
resides in the invasiveness of glioma cells and that mesenchymal
cells are component of the tumor microenvironment and may
modulate this migratory capacity (Behnan et al., 2014).
In addition, our data suggest that prolonged co-culture of
UC-MSCs and CSCs did not induce apparent apoptosis or
necrosis, in both cell populations within spheroids. However, the
direct co-culture caused a significant inhibition of both UC-MSC
and CSC proliferation rate. These results indicate that not only
UC-MSCs influence GBMCSC proliferation but also CSCsmight
influence the growth of UC-MSCs, possibly to gain support for
their invasiveness into surrounding tissue.
Conversely, the anti-proliferative effect of UC-MSCs was not
observed when CSC proliferation was evaluated after exposure
to UC-MSC CM, which rather increased CSC proliferation,
associated with a transient activation of ERK1/2 and Akt
intracellular signaling. The analysis of cytokine content within
the CM of UC-MSCs demonstrated a strong enrichment
of important tropic and trophic factors, including IL-6 and
the chemokines ENA-78 (a.k.a CXCL5), IL-8 (CXCL8) and
the GRO-related peptides (CXCL1, CXCL2 and CXCL3).
Importantly, CSCs, and in particular the CSC2 culture,
also release IL-8 and GROs. All CSCs express mRNA for
CXCR1 and CXCR2 when cultured in starved conditions
(w/o cytokines and growth factors), while in standard culture
conditions (stem cell medium) only weak mRNA expression
was detected in CSC1 and CSC3 but not in CSC2. This
evidence supports the activation of an autocrine/paracrine loop
in GBM CSCs, in which the abundant production of IL-8 and
GRO over-activates and then down-regulates CXCR2 mRNA
expression in standard culture conditions (paradoxically the
lower levels of expression may reflect the higher activation of
the pathway) whereas the receptor expression level increases
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FIGURE 10 | Expression levels of CXC chemokine receptor 1 (CXCR1) or CXCR2 in CSCs in basal or starved culture conditions. (A) Total RNA was isolated from
CSC1, CSC2 and CSC3 cultured in stem cell medium (SC) or starved (ST) for 48 h, and quantitative RT-PCR for CXCR1 or CXCR2 was carried out. Expression
values of ST were normalized to CSC1 SC levels (taken as 1), and data are expressed as the mean of three experiments ± SD. Data derived form the average of
two evaluations using independent mRNA extraction and cDNA amplification. (B) FACS analysis reporting CXCR2 expression in CSC1–3 cultures, grown in stem
medium (black lane) or in serum free medium for 48 h (dashed black line); Ab isotype signal is depicted by gray lines. At protein levels the culture conditions did not
affect CXCR2 expression. (C) Histograms showing CXCR2 expression in CSCs (black line) or UC-MSCs (dashed red line) cultured individually or co-cultured (dashed
lines) for 3 days. Ab isotype are shown in both conditions (gray lines). The expression of CXCR2 in both CSCs and UC-MSCs was not modified by co-culturing.
only after the removal of chemokines from the medium
(cell starvation). A similar regulatory mechanism has been
described for another chemokine receptor (CXCR4) in GBM
CSCs (Gatti et al., 2013). This mechanism was confirmed
analyzing CXCR2 expression at protein level by FACS that
indeed confirmed the significant presence of CXCR2 in both
CSCs and UC-MSCs. Only marginal changes were observed
in the expression of CXCR2 in CSCs and UC-MSCs when
co-cultured.
CSC proliferation induced by UC-MSC CM was mediated, at
least in part, by the activation of CXCR2. In fact, in the presence
of the CXCR2 antagonist SB225002, UC-MSC CM-dependent
cell proliferation was partially inhibited in all CSCs, but this
effect was more evident in CSC2 cells which spontaneously
release high levels of CXCR2 ligands, IL-8 and GRO. The
higher sensitivity of CSC2 to CXCR2 inhibition was also
demonstrated by SB225002 ability to reduce CSC2 migration,
while only minor effects were observed in CSC3, in agreement
with the lower production of CXCR2 ligands. These results, while
confirming the expected individual differences within GBM
CSC cultures, which reflect the distinct biological behavior and
molecular heterogeneity (mutations in EGFR, IDH1, IDH2, etc.)
of the original tumor, highlight how some GBM CSCs can be
dependent on chemokines for proliferation and migration, and
that these could be supplied not only by autocrine mechanisms
but also by cells within the tumor stroma (or the CSC niche),
including MSCs. However, we have to acknowledge that our
experimental model has some limitations since, although it
analyzes the interactions between CSCs and MSC in a 3D
environment, it does not include specific CNS cell populations
such as astrocytes and microglia. Importantly, these cells are
activated during GBM development resulting in high production
of cyto/chemokines. Thus, although the in vivo situation is
surely more complex than that reproduced in our model,
the establishment of the role of the cytokine milieu in the
control of GBM progression, as we report, is of extreme
relevance. Further studies, more specifically addressing the
involvement also of astrocytes and microglia, will complete our
observations.
Similar effects of cytokines were observed in different tumor
models. For example in ovarian cancer, ovarian MSCs release
IL-6 to promote proliferation and colony formation (Ding
et al., 2016) with a mechanism similar to that we observed
with CXCR2 ligands. Nevertheless, in our study SB225002 did
not interfere with CSC or UC-MSC spheroid formation and
invasion in the co-culture experiments. While we cannot
exclude that the close adhesion occurring in spheroids among
UC-MSCs and CSCs prevents the access of the inhibitor
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FIGURE 11 | Effects of the CXCR2 antagonist SB225002 on CSC growth dependent or independent from CM, spheroid CSC/UC-MSC co-culture formation and
cell migration. (A) CSC1, CSC2 and CSC3 were pretreated for 48 h in standard growth condition with SB225002 (50 nM) for 48 h, and then were challenged with
seven different UC-MSC CM for 72 h or in serum free medium (DMEM/F12), in the presence or in absence of SB225002, before MTT assays. Histograms represent
the average of the effects of all the seven distinct CM used in this study ± SEM. Data are expressed as % of cell growth in CM or DMEM/F12 in absence of the
inhibitor taken as 100%. Statistical analysis was performed using the Mann-Whitney test. ∗P < 0.05 and ∗∗P < 0.01. (B) Co-culture of GFP-CSC2 and GFP-CSC3
(green) and DiI-stained UC-5-MSC (red) spheroids for 1 and 6 days in the presence or in absence of SB225002 (similar results were also obtained using UC-6-MSC).
Images were acquired by confocal laser microscopy. Scale bar, 53 µm. (C) Representative images of transwell migration assays on GFP-CSC2 and GFP-CSC3
untreated (CTR) or treated with SB225002 (50 nM). Scale bar, 160 µm. (D) Cell migration through transwell inserts was quantified measuring the intensity of
fluorescence of migrated cells from four different confocal fluorescence images. Histograms represent the mean fluorescence intensity expressed as AU ± SD.
Statistical analysis was performed by the unpaired t-test ∗∗P < 0.01.
inside the spheroid, we hypothesize that the physical contact
between GBM CSCs and UC-MSCs, likely regulated by adhesion
molecules, modifies the release of or response to chemotactic
factors.
Thus, a completely different scenario can be drawn as
far as UC-MSC modulation of GBM CSCs proliferation,
according to the occurrence of a direct interaction between the
different cell populations (mainly showing antiproliferative
activity, independent from cyto/chemokine release and
CXCR2 activation), or when the interaction is mediated
by soluble factors, and CXCR2 ligands in particular, which
determine an opposite response (CSC proliferation and
activation of migration).
GROs and IL-8, highly secreted by both UC-MSCs and
CSCs, share the same receptors CXCR1 and CXCR2 with other
chemokines (ENA-78, GCP-2 and NAP-2). CXCR2 exerts its
canonical activity regulating neutrophil migration from bone
marrow and their recruitment into sites of inflammation.
In addition, CXCR2 has been identified as a fundamental
mediator in tumorigenesis not only in malignant tumors (Liu
et al., 2016) but also in pituitary adenomas (Barbieri et al.,
2011). High expression of IL-8 and its receptors in tumor
microenvironment might support tumor progression via the
establishment of pro-inflammatory signaling in tumor cells,
promoting proliferation, angiogenesis, migration and invasion of
cancer cells and, through paracrine signals, acting also on stromal
and endothelial cells (Campbell et al., 2013).
GROs were initially isolated from the CM of a melanoma cell
line (Richmond and Thomas, 1988) and their role in promoting
tumorigenesis was identified in several tumors. Downregulation
of CXCR1 and CXCR2, by interfering siRNA, inhibits melanoma
tumor growth and cell invasion (Singh et al., 2010); similarly
RNAi of GROα suppresses tumor growth in hepatocellular
carcinoma (Han et al., 2016). In GBM cell lines, GROα promotes
tumor growth, in vitro cell motility and invasiveness and
enhances tumor cell spread in vivo (Zhou et al., 2005). This
chemokine was also reported to activate the recruitment of bone
marrow MSCs into diffuse-type gastric cancer stroma and the
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inhibition of migration in tumor microenvironment induced by
the CXCR2 antagonist SB225002, decreases tumor volume and
metastasis (Kasashima et al., 2016). GROα and β also facilitate the
development of lung metastases and chemoresistance in breast
cancer through paracrine activation of CD11b+/Gr1+ myeloid
cells within tumor stroma, which in turn produces chemokines
able to enhance cancer cell survival. Thus, CXCR2 blockers were
proposed to improve the efficacy of chemotherapy by blocking
this paracrine reaction in the tumor stroma (Acharyya et al.,
2012).
Overall this evidence, and the data we provide in this study,
make difficult, at least in our tumor model, to match the
UC-MSC secretome and the high levels of CXCR2 ligands
with the anti-angiogenic and anti-inflammatory properties
generally attributed to mesenchymal cells. However, the close
cell-to-cell interactions between CSCs and MSCs occurring
in spheroids, could completely change their mutual state in
the microenvironment, inducing the modulation of adhesion
proteins able to inhibit proliferative intracellular pathways; we
did not rule out that in vivo this mechanism could represent the
prevalent condition.
Altogether our results demonstrate that direct (cell-to-cell
contact) or indirect (via the release of soluble factors) interactions
between GBM CSCs and UC-MSCs in co-culture produce
divergent effects on cell growth, invasion and migration, with
the former mainly causing an inhibitory response and the latter
a stimulatory one, at least in part mediated by the paracrine
activation of CXCR2 by its ligands GROs and IL-8, which
emerged as main mediators of the indirect activation of cell
proliferation.
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